Company Overview - Bon Natural Life Limited (NASDAQ:BON) is a leading bio-ingredient solution provider in the natural, health, and personal care industry [1] - The company is based in the Cayman Islands and focuses on innovative formulations in the health sector [4] Recent Developments - From October 2024 to January 2025, the company achieved significant advancements in bio-manufacturing technology for tea pigments, reaching an industrial-leading yield rate of 12-16% while maintaining purity levels above 95% [1] - The company plans to pursue innovative tea pigment-based products aimed at gastrointestinal and metabolic health through strategic partnerships [3] Industry Insights - Tea pigments demonstrate significant biological properties, including lipid-lowering, blood glucose reduction, antioxidant effects, and anti-peptic ulcer benefits, indicating broad applicability across various health sectors [2] - The global tea pigment industry is projected to exceed $12 billion by 2025, highlighting the potential for innovative applications in the market [2]

BONDUELLE Head office: "La Woestyne" - 59173 Renescure - France Bonduelle a French S.C.A (Partnership limited by Shares) with a capital of 57 102 699,50 euros Registered under number : 447 250 044 ( Dunkerque Commercial and Companies Register) Press Release Villeneuve d'Ascq, April 1, 2025 Sale of our packaged salad business in Germany Our 4 flagship brands are Bonduelle, Ready Pac Foods, Cassegrain, Globus. Bonduelle is listed on Euronext Paris compartment B Euronext indices: CAC MID & SMALL – CAC FOOD PRO ...

XI'AN, China, March 20, 2025 (GLOBE NEWSWIRE) -- Bon Natural Life Limited (NASDAQ:BON) ("BON" or the "Company"), a leading bio-ingredient solution provider in the natural, health and personal care industry, announced a game-changing patent for a natural postbiotic ingredient designed to regulate blood sugar is gearing up for release. The Company has engineered a food-derived postbiotic formula for glycemic management, slated to hit shelves in the near term. When taken 10-30 minutes before meals, this breakt ...

Core Viewpoint - Univest Securities, LLC has successfully closed a Best Efforts Offering for Bon Natural Life Limited, a prominent provider of bio-ingredient solutions in the natural health and personal care sectors, raising approximately $12 million in gross proceeds [1][4]. Group 1: Offering Details - The offering consisted of 8,333,332 shares of Class A ordinary shares and included Series A and Series B Warrants with exercise prices of $1.44 and $2.16 per share, respectively [2]. - Each ordinary unit was priced at $1.44, while pre-funded units were priced at $1.439 [3]. - The Warrants are immediately exercisable upon issuance and will expire three years after their initial exercise date [2]. Group 2: Use of Proceeds - The net proceeds from the offering will be allocated towards sales network expansion, research and development, production capacity expansion, and general corporate purposes [4]. Group 3: Company Information - Bon Natural Life Limited is based in the Cayman Islands and operates within the natural health and personal care industries [8]. - Univest Securities, LLC, established in 1994, provides a range of financial services including investment banking and advisory, and acts as the sole placement agent for this offering [7].

Core Insights - The materials sector has several oversold stocks, presenting potential buying opportunities for undervalued companies [1] - The Relative Strength Index (RSI) is a key indicator for identifying oversold conditions, typically below 30 [1] Company Summaries - **Bon Natural Life Ltd (BON)**: Recently announced a $12 million offering of 8,333,332 shares at $1.44/share. The stock has fallen approximately 53% over the past month, with a 52-week low of $0.55. Current RSI is 29.5, and shares closed at $0.61 after a 57.5% dip [3] - **ZK International Group Co Ltd (ZKIN)**: Resolved Nasdaq bid price deficiency and remains compliant. The stock has decreased around 27% in the last month, with a 52-week low of $1.24. Current RSI is 28, and shares closed at $1.30 [3] - **Perimeter Solutions Inc (PRM)**: Reported positive quarterly results but saw a stock decline of about 24% over the past month, with a 52-week low of $6.01. Current RSI is 29.8, and shares closed at $9.09 after a 1.4% drop [3]

Core Viewpoint - Bon Natural Life Limited has announced a best efforts offering of units for aggregate gross proceeds of $12 million, aimed at expanding its operations in the natural, health, and personal care industries [1][3]. Offering Details - The offering consists of 8,333,332 shares of Class A ordinary shares and associated Series A and Series B Warrants, with exercise prices of $1.44 and $2.16 per share respectively [2]. - The purchase price for each ordinary unit is set at $1.44, while pre-funded units will be priced at $1.439 [3]. - The offering is expected to close around March 18, 2025, pending customary closing conditions [3]. Use of Proceeds - The net proceeds from the offering will be utilized for sales network expansion, research and development, production capacity expansion, and general corporate purposes [3]. Placement Agent - Univest Securities, LLC is acting as the sole placement agent for this offering [4]. Company Background - Bon Natural Life Limited is a Cayman Islands company focused on providing bio-ingredient solutions in the natural, health, and personal care sectors [6].

Core Points - The company Bonduelle has released its Half Year Financial Report for the period ending December 31, 2024 [3] - The report has been filed with the AMF and is accessible on the company's official website [3][4] - Bonduelle is a French S.C.A with a registered capital of 57,102,699.50 euros [2]

Core Insights - The Bonduelle Group reported a strong growth of +17.8% in current operating income for the first half of the 2024-2025 fiscal year, amounting to 48 million euros, compared to 40.6 million euros in the previous fiscal year [4][22] - Despite a slight decline in overall sales, branded activities showed a growth of +1.9%, highlighting the strategic importance of brand development [6][10] - The company confirmed its annual objectives despite challenges such as poor agricultural harvests in Russia impacting profitability in the second half of the fiscal year [7][38] Financial Performance - Total sales for the first half of fiscal year 2024-2025 were 1,119.4 million euros, a decrease of -1.7% compared to 1,139.2 million euros in the previous fiscal year [5][15] - The current operating margin improved to 4.3%, up from 3.6% in the previous year, reflecting operational efficiency [14][22] - Net income from continuing operations increased significantly to 17.2 million euros, compared to 6.4 million euros in the previous fiscal year, representing 1.5% of sales [29] Sales Breakdown - Sales in the Europe Zone decreased by -5.6% on reported figures, primarily due to a decline in private label canned activities [16][18] - The Non-Europe Zone experienced growth of +4.8% on reported figures, with North America returning to growth for the first time in four years [20][24] - The canned segment saw a decline of -6.7%, while fresh processed activities grew by +4.7% [17] Strategic Initiatives - The "Transform to win" transformation plan is underway, focusing on brand development and operational excellence [9][10] - The company is working towards achieving a 100% B Corp group certification by the end of the year, emphasizing its commitment to sustainability [10] - Plans to sell the packaged salad activity in France and Germany are in progress, with agreements reached regarding employee support during the transition [35][36] Financial Situation - Net financial debt stood at 664 million euros as of December 31, 2024, an increase from 649 million euros the previous year [33] - The gearing ratio increased to 1.23 from 0.95, indicating a higher level of financial leverage [33] - The average financing rate decreased to 4.12%, reflecting improved debt management [27]

Core Insights - Bonduelle Group's sales for the first half of fiscal year 2024-2025 amounted to €1,119.4 million, reflecting a decline of 1.5% on a like-for-like basis and 1.7% on reported figures compared to the previous fiscal year [2][6][20] - The growth in branded activities was 1.9%, highlighting the strategic focus on brand development, while the private label segment saw a significant decline of 6.9% [3][6] - The company is in the process of selling its packaged salad activities in France and Germany, which will be reported under "net income from discontinued operations" [4][13][21] Sales Performance - Total sales in the Europe Zone decreased by 5.6% on reported figures and 5.8% on a like-for-like basis, primarily due to a drop in private label canned activities [6][9] - The Non-Europe Zone experienced growth of 4.8% on reported figures and 5.8% on a like-for-like basis, driven by strong retail sales in North America [11][12] - Sales by operating segments showed a decline in canned products by 6.7%, while fresh processed products grew by 4.7% [8][26] Financial Reporting - The financial statements will exclude the packaged salad activity in France and Germany in accordance with IFRS 5, affecting the reported sales figures [4][21] - The company plans to recognize a non-recurring item related to the redundancy plan and restructuring of the head office in the financial statements by December 31, 2024 [15][20] Future Outlook - Bonduelle Group will announce its sales and profitability outlook for the 2024-2025 fiscal year on March 5, 2025 [20][25]

Financial Performance - Revenues for the year ended September 30, 2024, were $23,844,556, a decrease of 19.5% compared to $29,522,353 in 2023[49]. - Gross profit decreased to $7,110,009 in 2024 from $8,840,027 in 2023, reflecting a decline of 19.5%[49]. - Operating expenses increased significantly to $5,236,475 in 2024, up from $2,903,566 in 2023, marking an increase of 80.3%[49]. - Net income attributable to Bon Natural Life Limited was $398,172 in 2024, down 91.3% from $4,595,982 in 2023[49]. - Earnings per share (basic) dropped to $0.17 in 2024 from $5.03 in 2023, a decline of 96.6%[49]. Assets and Liabilities - As of September 30, 2024, total assets increased to $61,765,432 from $46,556,136 in 2023, representing a growth of approximately 32.6%[48]. - Current assets rose to $39,793,857 in 2024, up from $24,183,464 in 2023, indicating an increase of about 64.5%[48]. - Total equity increased to $44,349,539 in 2024, compared to $35,981,833 in 2023, reflecting a growth of approximately 23.1%[48]. - Current liabilities grew to $16,445,832 in 2024 from $9,611,215 in 2023, marking an increase of around 71.5%[48]. - Total liabilities rose to $17,415,893 in 2024, up from $10,574,303 in 2023, which is an increase of approximately 64.9%[48]. Regulatory and Compliance Issues - The company is subject to the Holding Foreign Companies Accountable Act, which could impact its ability to trade on U.S. exchanges if its auditor is not inspected by the PCAOB for two consecutive years[27]. - The company believes it has obtained all necessary licenses and permits for its operations in China, but future regulatory changes could impact its business[40]. - The company is subject to the complex and rapidly evolving laws and regulations in China, which may impact its operations and the value of its ordinary shares[78]. - The Draft Rules Regarding Overseas Listing have not yet gone into effect, creating uncertainty regarding future regulatory approvals for overseas listings[91]. - The company may face additional compliance requirements if the Draft Rules Regarding Overseas Listing are enacted, which could hinder its ability to offer securities[91]. Business Strategy and Development - The company plans to invest in expanding its direct sales force and distribution channels to meet increasing product demand[61]. - New product development focuses on health supplements aimed at boosting immunity and improving sleep quality, among other benefits[59]. - The company estimates a capital need of approximately $40 million for expansion and development efforts[68]. Risks and Challenges - The inability to retain key personnel may adversely affect the company's financial condition and operational success[69]. - Increased competition from firms with greater capital resources poses a risk to the company's market share and profitability[66]. - The Chinese economy has experienced uneven growth, with a slowing growth rate since 2012, which could adversely affect the company's business and operating results[97]. - The company may incur material product liability claims due to the nature of its ingestible products, which could increase costs and harm financial condition[98]. Shareholder and Dividend Information - The company has not made any dividends or distributions to shareholders and intends to retain future earnings for business expansion[36]. - As of September 30, 2024, the accumulated profits available for dividends from the PRC subsidiary were $18,741,685, compared to $18,703,996 as of September 30, 2023, reflecting a slight increase[118]. - The statutory surplus reserves of the PRC subsidiary ranged from 2% to 41% of their respective registered capitals, averaging 25% in aggregate as of September 30, 2024[118]. - The withholding tax rate applicable to dividends payable by Chinese companies to non-PRC-resident enterprises is generally 10%, but may be reduced to 5% for Hong Kong enterprises under certain conditions[121]. Internal Controls and Governance - The company identified several material weaknesses in its internal control over financial reporting as of September 30, 2024, due to a lack of qualified accounting staff[187]. - Remedial measures have been initiated, including hiring qualified accounting personnel and implementing training programs for financial reporting[189]. - The company has not fully addressed the identified weaknesses in internal controls, which could impact financial statement accuracy and regulatory compliance[191]. Tax and Compliance Obligations - Bon Natural Life Limited recorded tax liabilities of $3.7 million as of September 30, 2024, including $1.7 million in income tax payable and $1.4 million in unpaid value-added taxes (VAT)[154]. - The statutory enterprise income tax rate in China is 25%, but companies recognized as high and new technology enterprises can benefit from a reduced rate of 15%[159]. - If Bon Natural Life Limited is classified as a PRC resident enterprise, it would be subject to a 25% tax on worldwide income, significantly impacting net income[152]. Currency and Financial Risks - Fluctuations in the Renminbi against the U.S. dollar may significantly impact the company's operational results and investment value, with a noted appreciation of over 20% against the U.S. dollar from 2005 to 2008[136]. - Limited hedging options in China may restrict the company's ability to mitigate foreign currency exchange risks, with no hedging transactions entered to date[138]. - Governmental controls on currency conversion may hinder the effective utilization of revenues, requiring SAFE approval for converting Renminbi into foreign currencies for capital expenses[140]. Corporate Structure and Financing - The company is incorporated under Cayman Islands law, which may limit shareholders' rights compared to U.S. domestic issuers[178]. - The company has established a wholly foreign-owned enterprise in China to facilitate operations and financing[195]. - The company completed a private offering of $5,600,000 worth of ordinary shares at a price of $2.29 per share, issuing a total of 2,445,415 shares along with warrants for additional shares[210].